• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME MONITOR Back to Search Results
Model Number XS PST
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Speech Disorder (4415); Hemorrhagic Stroke (4417); Insufficient Information (4580)
Event Date 04/01/2020
Event Type  Injury  
Manufacturer Narrative
The meter was requested for investigation.The customer returned the meter and the strips.They were tested using a retention meter and retention controls.Testing results (qc range = 4.1 - 6.8 inr): qc 1: 5.2 inr, qc 2: 5.4 inr, and qc 3: 5.9 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.Error 5 was saved on the meter's log on (b)(6) 2022 and (b)(6) 2022.Product labeling states: "error: blood application - error applying blood to the test strip.Solution: turn the meter off and remove the test strip.Repeat the test using a new test strip and blood taken from a new fingerstick from a different finger." on a regular basis, coaguchek strips of all lots currently valid in the market are tested in comparison to the current master lot at roche mannheim.For this purpose, the strips are measured with two human blood samples from marcumar donors and one high-level control sample on internal reference meters.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Event Description
While troubleshooting an "error 5" message on the coaguchek meter the reporter mentioned that 2 years ago, he was allegedly unable to test on his meter due to an error and allegedly had a brain bleed a few days later.The exact date was unknown by the reporter.Based on this information the date of the event is an estimate.The reporter could not recall the error message he received 2 years ago.After a few days of not being able to test, the reporter stated that he went to the emergency room "due to a brain bleed".His inr result at the hospital from an unspecified source was reported to be 12.5.He stated that he did not receive any medical treatment while at the hospital and was sent home.The next day, the reporter stated that he was found to be in a coma at home and was care flighted to the hospital.He stated that he did not receive any medical treatment and was sent home.He further stated that he permanently has brain and speech damage due to the brain bleed.The patient's therapeutic range was reported to be 2.5-3.0 inr and testing is performed weekly.This mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
The error code memory log started on (b)(6) 2020 and the date of the event is (b)(6) 2020.The investigation is unable to comment further on errors obtained on or before the date of the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME MONITOR
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14252873
MDR Text Key291292055
Report Number1823260-2022-01224
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702125100
UDI-Public00365702125100
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberXS PST
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/18/2022
Is the Reporter a Health Professional? No
Date Manufacturer Received06/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALLOPURINOL; AMLODIPINE; ASPIRIN; ATORVASTATIN; CENTRUM WOMEN'S MULTIVIT K 50 MCG 42% DAILY INTAKE; CINNAMON; FISH OIL; FUROSEMIDE; LISINOPRIL; LORATIDINE; METOPROLOL; MULTAQ; OMEPRAZOLE; VITAMIN C; WARFARIN
Patient Outcome(s) Disability; Hospitalization;
Patient Age77 YR
Patient SexMale
Patient Weight95 KG
-
-